drugset / Trial / NCT06139575
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
NaSequentialOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of Lutetium Lu 177 JH020002 Injection in adult patients with advanced prostate cancer.
Timeline
- Start
- 2023-12-22
- Primary completion
- 2026-05
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JH020002 | Unknown | 1850 mbq | — |
| Subject | JH020002 | Unknown | 8880 mbq | — |